Skip to main content

Featured Stories

Commentary
March 01, 2021
Ann Latner, JD, breaks down three legal cases including, a pharmacist who plead guilty to federal charges for sabotaging COVID-19 vaccines and an Alaska pharmacy that was fined for prescription…
News
February 26, 2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of…
News
February 25, 2021
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the…
Interview
February 24, 2021
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health…
Commentary
February 24, 2021
Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, discusses survey results concerning compounding technologies and common safety…
Commentary
February 23, 2021
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this…
Commentary
February 19, 2021
“Reports of low influenza activity thus far have eased the anxieties and fears of many individuals during this ongoing COVID-19 pandemic,” says…
News
February 19, 2021
Two batches of enoxaparin sodium injections are being recalled by Apotex Corp. because of incorrect dosage markings on some syringe barrels.
Commentary
February 10, 2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health…
Back to Top